Meeting
2022 ASCO Annual Meeting
Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC).
Authors
Naomi B. Haas
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Naomi B. Haas , Rituparna Bhattacharya , Yan Song , Jackie Rogerio , Su Zhang , Christopher Carley , Annika Anderson , James Signorovitch , Murali Sundaram
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4543)
DOI
10.1200/JCO.2022.40.16_suppl.4543
Abstract #
4543
Poster Bd #
34
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Adjuvant pembrolizumab (pembro) for renal cell carcinoma (RCC) across UCLA Integrated Staging System (UISS) risk groups and disease stage: Subgroup analyses from the KEYNOTE-564 study.
First Author: Toni K. Choueiri
Poster
2023 ASCO Genitourinary Cancers Symposium
Creatinine to cystatin C ratio and mortality in renal cell carcinoma.
First Author: Benjamin Schmeusser
Poster
2018 Genitourinary Cancers Symposium
Association of dividing pathologically upstaged T3a renal cell carcinoma with improved alignment of outcomes: A call for TMN revision.
First Author: Zachary Hamilton
Poster
2013 Genitourinary Cancers Symposium
Analysis of molecular profiling of renal cell carcinoma: Identification of a 4-microRNA signature as a prognostic value in patients with stage I-II disease.
First Author: Daniel E. Castellano